Literature DB >> 5870517

Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom.

S H Ferreira, M Rocha e Silva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5870517     DOI： 10.1007/bf02144709

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  5 in total

1.  A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA.

Authors:  S H FERREIRA
Journal:  Br J Pharmacol Chemother       Date:  1965-02

2.  Hemodynamic effects of eledoisin, kallidin II, and bradykinin in unanesthetized dogs.

Authors:  F OLMSTED; I H PAGE
Journal:  Am J Physiol       Date:  1962-11

3.  A comparative pharmacological study of synthetic eledoisin and synthetic bradykinin.

Authors:  E STURMER; B BERDE
Journal:  J Pharmacol Exp Ther       Date:  1963-06       Impact factor: 4.030

4.  Concerning the theory of receptors in pharmacology; a rational method of estimation of pAx.

Authors:  M ROCHA E SILVA
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-01-01

5.  The action of eledoisin on the systemic arterial blood pressure of some experimental animals.

Authors:  V Erspamer; A Glaesser
Journal:  Br J Pharmacol Chemother       Date:  1963-06
  5 in total
  15 in total

Review 1.  Historical perspective of the renin-angiotensin system.

Authors:  John E Hall
Journal:  Mol Biotechnol       Date:  2003-05       Impact factor: 2.695

2.  Involvement of Kallikrein-Kinin System on Cardiopulmonary Alterations and Inflammatory Response Induced by Purified Aah I Toxin from Scorpion Venom.

Authors:  Wafa Medjadba; Marie-France Martin-Eauclaire; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

3.  Primary structure and biological activity of bradykinin potentiating peptides from Bothrops insularis snake venom.

Authors:  A C Cintra; C A Vieira; J R Giglio
Journal:  J Protein Chem       Date:  1990-04

4.  History of the development of inhibitors of angiotensin I conversion.

Authors:  S H Ferreira
Journal:  Drugs       Date:  1985       Impact factor: 9.546

5.  Analysis of vasodilatation in the submaxillary gland using potentiators of acetylcholine and kinins.

Authors:  M Schachter; S Barton; E Karpinski
Journal:  Experientia       Date:  1973-08-15

6.  Liberation of a bradykinin-like substance in the circulating blood of dogs by trypsin, chymotrypsin and nagarse.

Authors:  S H Ferreira; M Rocha E Silva
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

7.  The inactivation of bradykinin in the pulmonary circulation of isolated lungs.

Authors:  V A Alabaster; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1972-06       Impact factor: 8.739

8.  Action of bradykinin potentiating factor (BPF) and dimercaprol (BAL) on the responses to bradykinin of isolated preparations of rat intestines.

Authors:  A Camargo; S H Ferreira
Journal:  Br J Pharmacol       Date:  1971-06       Impact factor: 8.739

Review 9.  Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.

Authors:  Mahjabin Khan; Tao Huang; Cheng-Yuan Lin; Jiang Wu; Bao-Min Fan; Zhao-Xiang Bian
Journal:  Oncotarget       Date:  2017-06-07

Review 10.  The modular nature of bradykinin-potentiating peptides isolated from snake venoms.

Authors:  Juliana Mozer Sciani; Daniel Carvalho Pimenta
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.